Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Neocytogen Theraputics works in Biotechnology Research, out of Singapore. It is privately held, and its site is neocytogen.com. It holds three addresses on record across two office countries. Headcount on record is 4. Its work is tagged biotechnology, research and medicine. The record links five similar brands, most of them in Biotechnology Research.
Neocytogen Therapeutics is a biotechnology company focusing on universal cell and gene therapy, committed to developing innovative therapies for malignant tumors and chronic diseases. The company's core technologies include universal CAR-X platform, iPSC platform, next generation oncolytic virus platform, and exosome technology platform. The founding team of Neocytogen is composed of senior scientists from the National University of Singapore and Nanyang Technological University. The company is headquartered in Singapore, with R&D centers in Singapore and Shanghai, China. We are also building an integrated center of R&D and production in Singapore to support future technology translation and clinical applications, enabling us to become a global leader in universal cell therapy.
For more information, please refer to our website.
| Countries | 2 |
|---|---|
| Primary country | SG |
All codes: SG CN
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
Three addresses on record across 2 countries. Primary: 1 Venture Avenue, Singapore, #01-08, Perennial Business City, Singapore 608521.
None linked to this brand.
Seven tags on the brand's own list, among them biotechnology, research and medicine.
7 profiles list Neocytogen Theraputics as a peer — 73rd percentile in Biotechnology Research. It lists ten peers of its own. Blue Unicorn Capital and Neurocyte list it back.